Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets

P. Soon-Shiong, Edward C Feldman, Richard W Nelson, J. Komtebedde, O. Smidsrod, G. Skjak-Braek, T. Espevik, R. Heintz, M. Lee

Research output: Contribution to journalArticle

166 Citations (Scopus)

Abstract

Long-term euglycemia by intraperitoneal transplantation of microencapsulated islets has not been described in the diabetic large animal model. In this study, we report the successful long-term reversal of diabetes by this method in spontaneous diabetic dogs. We have identified fundamental mechanism(s) associated with alginate-based microcapsule fibrosis, and have devised methods to ameliorate this problem. These include the use of purified alginate of low mannuronic acid content and cytokine suppression. Ten insulin-dependent, spontaneous diabetic dogs (insulin requirement 1-4 units/kg/day; absence of circulating C-peptide and diabetic K-values of 0.6±0.4) were entered into the study. Islets from mongrel donor pancreata were isolated and transplanted intraperitoneally either as free islet controls (n=3) or as microencapsulated islet allografts (n=7). In all seven encapsulated islet recipients, euglycemia was achieved within 24 hr (serum glucose falling from 304±117 to 116±72 mg/dl). IVGTT performed 14 days after islet transplant demonstrated normalization of K-values changing from a pretransplant level of 0.6±0.4 to 2.6±0.6. All animals receiving encapsulated islets remained euglycemic, free of the need for exogenous insulin, for a period of 63-172 days, with a median insulin-independence for 105 days. In contrast, recipients receiving free islets rejected their graft within seven days of implantation. In conclusion, this is the first report of long-term successful reversal of spontaneous diabetes in the large animal model by an intraperitoneal injection of encapsulated islets. The potential exists for this form of therapy to be explored in the treatment of type I diabetes in man.

Original languageEnglish (US)
Pages (from-to)769-774
Number of pages6
JournalTransplantation
Volume54
Issue number5
StatePublished - 1992

Fingerprint

Dogs
Insulin
Animal Models
Transplants
Islets of Langerhans Transplantation
C-Peptide
Intraperitoneal Injections
Type 1 Diabetes Mellitus
Capsules
Allografts
Pancreas
Fibrosis
Tissue Donors
Cytokines
Glucose
Therapeutics
Serum
alginic acid
mannuronic acid

ASJC Scopus subject areas

  • Immunology
  • Transplantation

Cite this

Soon-Shiong, P., Feldman, E. C., Nelson, R. W., Komtebedde, J., Smidsrod, O., Skjak-Braek, G., ... Lee, M. (1992). Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation, 54(5), 769-774.

Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. / Soon-Shiong, P.; Feldman, Edward C; Nelson, Richard W; Komtebedde, J.; Smidsrod, O.; Skjak-Braek, G.; Espevik, T.; Heintz, R.; Lee, M.

In: Transplantation, Vol. 54, No. 5, 1992, p. 769-774.

Research output: Contribution to journalArticle

Soon-Shiong, P, Feldman, EC, Nelson, RW, Komtebedde, J, Smidsrod, O, Skjak-Braek, G, Espevik, T, Heintz, R & Lee, M 1992, 'Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets', Transplantation, vol. 54, no. 5, pp. 769-774.
Soon-Shiong, P. ; Feldman, Edward C ; Nelson, Richard W ; Komtebedde, J. ; Smidsrod, O. ; Skjak-Braek, G. ; Espevik, T. ; Heintz, R. ; Lee, M. / Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. In: Transplantation. 1992 ; Vol. 54, No. 5. pp. 769-774.
@article{ec2b87d7c8354cd3b934dc522359042c,
title = "Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets",
abstract = "Long-term euglycemia by intraperitoneal transplantation of microencapsulated islets has not been described in the diabetic large animal model. In this study, we report the successful long-term reversal of diabetes by this method in spontaneous diabetic dogs. We have identified fundamental mechanism(s) associated with alginate-based microcapsule fibrosis, and have devised methods to ameliorate this problem. These include the use of purified alginate of low mannuronic acid content and cytokine suppression. Ten insulin-dependent, spontaneous diabetic dogs (insulin requirement 1-4 units/kg/day; absence of circulating C-peptide and diabetic K-values of 0.6±0.4) were entered into the study. Islets from mongrel donor pancreata were isolated and transplanted intraperitoneally either as free islet controls (n=3) or as microencapsulated islet allografts (n=7). In all seven encapsulated islet recipients, euglycemia was achieved within 24 hr (serum glucose falling from 304±117 to 116±72 mg/dl). IVGTT performed 14 days after islet transplant demonstrated normalization of K-values changing from a pretransplant level of 0.6±0.4 to 2.6±0.6. All animals receiving encapsulated islets remained euglycemic, free of the need for exogenous insulin, for a period of 63-172 days, with a median insulin-independence for 105 days. In contrast, recipients receiving free islets rejected their graft within seven days of implantation. In conclusion, this is the first report of long-term successful reversal of spontaneous diabetes in the large animal model by an intraperitoneal injection of encapsulated islets. The potential exists for this form of therapy to be explored in the treatment of type I diabetes in man.",
author = "P. Soon-Shiong and Feldman, {Edward C} and Nelson, {Richard W} and J. Komtebedde and O. Smidsrod and G. Skjak-Braek and T. Espevik and R. Heintz and M. Lee",
year = "1992",
language = "English (US)",
volume = "54",
pages = "769--774",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets

AU - Soon-Shiong, P.

AU - Feldman, Edward C

AU - Nelson, Richard W

AU - Komtebedde, J.

AU - Smidsrod, O.

AU - Skjak-Braek, G.

AU - Espevik, T.

AU - Heintz, R.

AU - Lee, M.

PY - 1992

Y1 - 1992

N2 - Long-term euglycemia by intraperitoneal transplantation of microencapsulated islets has not been described in the diabetic large animal model. In this study, we report the successful long-term reversal of diabetes by this method in spontaneous diabetic dogs. We have identified fundamental mechanism(s) associated with alginate-based microcapsule fibrosis, and have devised methods to ameliorate this problem. These include the use of purified alginate of low mannuronic acid content and cytokine suppression. Ten insulin-dependent, spontaneous diabetic dogs (insulin requirement 1-4 units/kg/day; absence of circulating C-peptide and diabetic K-values of 0.6±0.4) were entered into the study. Islets from mongrel donor pancreata were isolated and transplanted intraperitoneally either as free islet controls (n=3) or as microencapsulated islet allografts (n=7). In all seven encapsulated islet recipients, euglycemia was achieved within 24 hr (serum glucose falling from 304±117 to 116±72 mg/dl). IVGTT performed 14 days after islet transplant demonstrated normalization of K-values changing from a pretransplant level of 0.6±0.4 to 2.6±0.6. All animals receiving encapsulated islets remained euglycemic, free of the need for exogenous insulin, for a period of 63-172 days, with a median insulin-independence for 105 days. In contrast, recipients receiving free islets rejected their graft within seven days of implantation. In conclusion, this is the first report of long-term successful reversal of spontaneous diabetes in the large animal model by an intraperitoneal injection of encapsulated islets. The potential exists for this form of therapy to be explored in the treatment of type I diabetes in man.

AB - Long-term euglycemia by intraperitoneal transplantation of microencapsulated islets has not been described in the diabetic large animal model. In this study, we report the successful long-term reversal of diabetes by this method in spontaneous diabetic dogs. We have identified fundamental mechanism(s) associated with alginate-based microcapsule fibrosis, and have devised methods to ameliorate this problem. These include the use of purified alginate of low mannuronic acid content and cytokine suppression. Ten insulin-dependent, spontaneous diabetic dogs (insulin requirement 1-4 units/kg/day; absence of circulating C-peptide and diabetic K-values of 0.6±0.4) were entered into the study. Islets from mongrel donor pancreata were isolated and transplanted intraperitoneally either as free islet controls (n=3) or as microencapsulated islet allografts (n=7). In all seven encapsulated islet recipients, euglycemia was achieved within 24 hr (serum glucose falling from 304±117 to 116±72 mg/dl). IVGTT performed 14 days after islet transplant demonstrated normalization of K-values changing from a pretransplant level of 0.6±0.4 to 2.6±0.6. All animals receiving encapsulated islets remained euglycemic, free of the need for exogenous insulin, for a period of 63-172 days, with a median insulin-independence for 105 days. In contrast, recipients receiving free islets rejected their graft within seven days of implantation. In conclusion, this is the first report of long-term successful reversal of spontaneous diabetes in the large animal model by an intraperitoneal injection of encapsulated islets. The potential exists for this form of therapy to be explored in the treatment of type I diabetes in man.

UR - http://www.scopus.com/inward/record.url?scp=0026540343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026540343&partnerID=8YFLogxK

M3 - Article

C2 - 1440841

AN - SCOPUS:0026540343

VL - 54

SP - 769

EP - 774

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 5

ER -